Showing results (291-300 of 336) with videos related to

Sort By:
Pageof 34
Cancer Letters|November 20, 2023
RNA-binding protein hnRNPU regulates multiple myeloma resistance to selinexorXin Wang, Juan Xu, Qun Li, et al.
Cell Death & Disease|May 16, 2021
BMI1 regulates multiple myeloma-associated macrophage's pro-myeloma functionsDanfeng Zhang, Jingcao Huang, Fangfang Wang, et al.
Scientific Reports|August 24, 2017
Evaluation of the new Chinese Disseminated Intravascular Coagulation Scoring System in critically ill patients: A multicenter prospective studyYingying Wu, Lili Luo, Ting Niu, et al.
World Journal of Pediatrics : WJP|February 27, 2023
A multicenter prospective study of next-generation sequencing-based newborn screening for monogenic genetic diseases in ChinaRu-Lai Yang, Gu-Ling Qian, Ding-Wen Wu, et al.
Thrombosis Research|December 12, 2018
A multicenter, prospective evaluation of the Chinese Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulationLili Luo, Yingying Wu, Ting Niu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 4, 2023
KMT2D Deficiency Promotes Myeloid Leukemias which Is Vulnerable to Ribosome Biogenesis InhibitionJing Xu, Ailing Zhong, Shan Zhang, et al.
Platelets|November 15, 2014
Immunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: A multicenter, observational studyXiao Hui Zhang, Ru Feng, Lan Ping Xu, et al.
Leukemia & Lymphoma|February 17, 2016
Sustaining integrating imatinib and interferon-α into maintenance therapy improves survival of patients with Philadelphia positive acute lymphoblastic leukemia ineligible for allogeneic stem cell transplantationPu Kuang, Ting Liu, Ling Pan, et al.
Signal Transduction and Targeted Therapy|June 25, 2025
Preclinical and first-in-human of purinostat mesylate, a novel selective HDAC I/IIb inhibitor, in relapsed/refractory multiple myeloma and lymphomaLinyu Yang, Qiang Qiu, Jie Wang, et al.
Oncology|August 10, 2005
Combination of low-dose gemcitabine and recombinant quail vascular endothelial growth factor receptor-2 as a vaccine induces synergistic antitumor activitiesJian-Mei Hou, Ji-Yan Liu, Li Yang, et al.
Pageof 34